Lululemon reported a first-quarter fiscal 2027 revenue beat and a two-cent EPS beat, but the stock's reaction tells the real story: the market doesn't care about a 4% top-line number when the core business is hemorrhaging in its home market. Americas comparable sales fell 6% in constant currency, a four-point acceleration, after being negative for roughly two years straight. The company also slashed its full-year FY2026 EPS guidance to $10.95–$11.15, down sharply from $13.26 in the prior year. That is the reset the analyst community was warning about - and it may not be finished.
My view: Hold. The valuation has compressed to the point where further downside is limited, but there is no visible catalyst to reverse the Americas comp trend. The risk/reward doesn't justify a Buy until Lululemon proves it can stabilize same-store sales in the market that generates the bulk of its revenue.
What changed
The headline metrics are a trap if you stop at the top line. Revenue came in at $2.5 billion, up 4% year over year (2% in constant currency), beating the $2.43 billion consensus. EPS of $1.69 came in two cents above the $1.67 estimate. On the surface, that reads like a mild beat.
But look below the line. Operating income fell 37% quarter over quarter. Net income dropped 38% to $195 million. The EPS beat was achieved by margin management, not by demand. The company is generating fewer dollars of profit on more revenue, which means pricing power is weakening or promotional intensity is rising - both of which matter when you're trying to justify a growth multiple.
Then comes the guidance. Management cut full-year FY2026 EPS guidance to $10.95–$11.15. Put that against FY2025 actual EPS of $13.26, and you're looking at an 18–20% earnings contraction. For the second quarter, revenue is expected to decline 2–3%. The target keeps moving lower, and there's no evidence the trend has bottomed.
The Americas problem
Here's the number that should drive the thesis: Americas comp sales of negative 6% in constant currency. This isn't a one-quarter blip. Comparable sales in Lululemon's core market have been negative for roughly two years, and the pace of decline accelerated by four points in this quarter. The Americas generate the vast majority of Lululemon's revenue; if that engine stalls, the rest of the company is a sideshow.
China is growing fast - revenue there jumped 30% to $478 million - but that represents roughly 19% of total sales. A 30% growth rate on 19% of revenue doesn't offset a 6% comp decline on the other 80%. The math doesn't work as a bridge strategy.
The valuation argument
This is where the cheap multiple camp makes its case. Lululemon's market cap sits at roughly $14.5 billion. The trailing P/E is around 9.5x, and forward P/E is approximately 10.1x. The stock has fallen roughly 38% in 2026 and trades near the bottom of its 52-week range ($116.63 to $339.15). The analyst consensus price target is around $186, implying roughly 50% upside.
A 9.5x P/E on a company with 19.9% EBIT margins, 56.6% gross margins, and $922 million in annual free cash flow is undeniably low. For context, Lululemon historically traded at 25–35x earnings when growth ran 15–25%. The multiple has collapsed faster than earnings have deteriorated. The question is whether the market is right to price this as a mature, low-growth retailer rather than a growth compounder.
The answer depends on what happens next. If Americas comps stay negative, the 9.5x multiple is fair for a company losing domestic traction. If comps stabilize and the China ramp continues, the multiple has room to re-expand. I don't see evidence of stabilization yet.
What would change the thesis
Three things would move me to Buy:
- Two consecutive quarters of positive Americas comps. One quarter isn't enough to prove trend reversal, but two would signal the core market has found a floor.
- FY2027 guidance that shows an EPS inflection point. The FY2026 cut to $10.95–$11.15 is a floor. I need to see management project that FY2027 earnings don't fall another step below that.
- A gross margin defense play. If management demonstrates that promotional intensity is being curtailed and full-price sell-through is recovering, it would suggest the comp decline is a volume timing issue rather than a demand erosion issue.
Conversely, the thesis breaks further to the downside if:
- Americas comps fall below negative 8%, suggesting structural demand loss rather than cyclical weakness.
- Free cash flow generation deteriorates, which would remove the balance-sheet support that makes the current valuation defensible.
- China growth decelerates sharply, eliminating the one growth bright spot.
The takeaway
Lululemon is a company with real operating discipline - the gross margin, the cash flow, the store optimization program - that is being dragged down by a domestic sales problem it hasn't solved in two years. The 9.5x P/E reflects that failure. It's cheap, but it's cheap for a reason that hasn't been resolved.
I'm holding at current levels because the valuation gives me margin of safety if things stabilize. But I'm not buying more until the Americas comp number stops getting worse. A beaten-down multiple is not a buying signal when the underlying growth story has no end date. Monitor the next quarter's Americas comps. That's the one number that decides whether Lululemon is a value opportunity or a value trap.